Immix Biopharma, Inc.

IMMX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$15,947$11,638$15,921$17,682
Short-Term Investments$0$0$0$0
Receivables$0$0$0$1,974
Inventory$0$0$0$0
Other Curr. Assets$637$688$858$542
Total Curr. Assets$16,584$12,325$16,779$20,198
Property Plant & Equip (Net)$3,364$3,179$3,092$2,730
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$132$131$20$20
Total NC Assets$3,496$3,310$3,113$2,750
Other Assets$0$0$0$0
Total Assets$20,081$15,635$19,892$22,948
Liabilities
Payables$7,050$6,614$5,742$5,388
Short-Term Debt$141$70$68$65
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,659$3,325$3,497$3,233
Total Curr. Liab.$10,851$10,010$9,307$8,687
LT Debt$965$972$991$1,010
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0-$0$0$0
Total NC Liab.$965$972$991$1,010
Other Liabilities$0$0$0$0
Cap. Leases$1,106$1,043$1,059$1,075
Total Liabilities$11,816$10,982$10,298$9,697
Equity
Pref Stock$0$0$0$0
Common Stock$3$3$3$3
Retained Earnings-$93,775-$86,190-$79,567-$75,025
AOCI$62$65$15-$1
Other Equity$101,975$90,775$89,142$88,274
Total Equity$8,265$4,653$9,594$13,251
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$20,081$15,635$19,892$22,948
Net Debt-$14,841-$10,595-$14,862-$16,607